Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dickstein

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1996
Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin TO Hetland, K Dickstein
Clinical Chemistry|June 13, 1998
Cardiac troponin T by Elecsys system and a rapid ELISA: analytical sensitivity in relation to the TropT (CardiacT) "bedside" testO Hetland, K Dickstein
European Heart Journal|January 1, 1985
A double-blind multiple crossover trial evaluating a transdermal nitroglycerin system vs placeboK Dickstein, H Knutsen
Drugs & Aging|July 1, 1997
Drug selection for optimal treatment of hypertension in the elderlyE Shammas, K Dickstein
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1985
[Transdermal nitroglycerin. Evaluation against a placebo in a double-blind multi-cross-over study]K Dickstein, H Knutsen
The American Journal of Cardiology|March 16, 2001
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist LosartanK Dickstein, J Kjekshus,
Expert Opinion on Pharmacotherapy|March 16, 2001
Pharmacotherapy following myocardial infarction--a review of current treatment practicesS Ørn, K Dickstein
American Journal of Ophthalmology|April 1, 1996
Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged menK Dickstein, T Aarsland
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 24, 2001
[Are emergency admissions to medical departments dependent on weather?]N H Tollefsen, K Dickstein
Drugs|March 1, 1996
Novel drugs and current therapeutic approaches in the treatment of heart failureV V Bonarjee, K Dickstein
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1996
Cardiac markers in the early hours of acute myocardial infarction: clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB subform ratios, myoglobin and cardiac troponin TO Hetland, K Dickstein
Clinical Chemistry|June 13, 1998
Cardiac troponin T by Elecsys system and a rapid ELISA: analytical sensitivity in relation to the TropT (CardiacT) "bedside" testO Hetland, K Dickstein
European Heart Journal|January 1, 1985
A double-blind multiple crossover trial evaluating a transdermal nitroglycerin system vs placeboK Dickstein, H Knutsen
Drugs & Aging|July 1, 1997
Drug selection for optimal treatment of hypertension in the elderlyE Shammas, K Dickstein
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 10, 1985
[Transdermal nitroglycerin. Evaluation against a placebo in a double-blind multi-cross-over study]K Dickstein, H Knutsen
The American Journal of Cardiology|March 16, 2001
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist LosartanK Dickstein, J Kjekshus,
Expert Opinion on Pharmacotherapy|March 16, 2001
Pharmacotherapy following myocardial infarction--a review of current treatment practicesS Ørn, K Dickstein
American Journal of Ophthalmology|April 1, 1996
Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged menK Dickstein, T Aarsland
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 24, 2001
[Are emergency admissions to medical departments dependent on weather?]N H Tollefsen, K Dickstein
Drugs|March 1, 1996
Novel drugs and current therapeutic approaches in the treatment of heart failureV V Bonarjee, K Dickstein
Pageof 11